This fusion gene is the molecular basis for the occurrence of CML.[4] Differences in the BCR or ABL gene breakpoints lead to the diversity of BCR::ABL fusion genes and clinical features. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.